• Return to Headlines

Relatively High Debt to EBITDA Ratio Detected in Shares of Albany Molecular in the Life Sciences Tools & Services Industry (AMRI, Q, VWR, NEO, TMO)

By Shiri Gupta

Below are the three companies in the Life Sciences Tools & Services industry with the highest debt to EBITDA ratios. This ratio indicates how many years of EBITDA would be necessary in order to pay back all the debt (assuming Debt and EBITDA are constant). Typically, this ratio is considered to be alarming when it is greater than 3.0 but this can vary and should be looked at within the context of the industry.

Albany Molecular ranks highest with a a debt to EBITDA ratio of 13.8. Quintiles Ims Ho is next with a a debt to EBITDA ratio of 7.5. Vwr Corp ranks third highest with a a debt to EBITDA ratio of 5.0.

Neogenomics Inc follows with a a debt to EBITDA ratio of 4.7, and Thermo Fisher rounds out the top five with a a debt to EBITDA ratio of 3.9.

SmarTrend recommended that subscribers consider buying shares of Albany Molecular on April 13th, 2017 as our technology indicated a new Uptrend was in progress when shares hit $15.39. Since that recommendation, shares of Albany Molecular have risen 41.3%. We continue to monitor Albany Molecular for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: highest debt to ebitda ratio albany molecular quintiles ims ho vwr corp neogenomics inc Thermo Fisher

Ticker(s): AMRI Q VWR NEO TMO